Annals of African Medicine · 2021 · 14 citations · 20 references
Life SciencesEndocrinologyInternal MedicineAutoimmunityDiabetologyImmunopathologyAutoantibodiesAutoantibody-mediated DiseaseAutoimmune BiomarkersAutoimmune DiseasesDiabetes MellitusOrgan-specific Autoimmune DiseasesAnti-glutamic Acid Decarboxylase AntibodiesAutoimmune Endocrine DiseaseAutoimmune Organ-specific DiseaseGlutamic Acid Decarboxylase AntibodiesIslet Cell DysfunctionOrgan-specific Autoimmune Disease MechanismsOrgan-specific AutoimmunityPancreatic Islet Cells
Background: Type 1 diabetes mellitus (T1DM) is an autoimmune disorder caused by pancreatic β-cells destruction. Anti-pancreatic antibodies are the witness of β-cell destruction and their dosage is mainly used for etiological diagnosis. Patients with T1DM are at increased risk of developing other autoimmune reactions, which may involve other organs, resulting in organ specific autoimmune disease. The most frequently encountered are autoimmune thyroid disease, followed by celiac and gastric disease and other rare autoimmune diseases. Objectives: The purpose of this study is to investigate the prevalence of autoimmune markers in patients with T1DM. Methods: The study was conducted at the Department of Endocrinology of the Military Hospital Moulay Ismail in Meknes Morocco, from January 2016 to December 2018. All Type 1 diabetes patients consulting during the study period were included in the study. Their clinical and biochemical data were collected at their first presentation, made up of anti-pancreatic antibodies (glutamic acid decarboxylase [GAD] antibody, tyrosine phosphatase antibody, and islet cell antibody) and other organ-specific antibodies: the thyroid (antithyroid peroxidase antibody, antithyroglobulin antibody, and antithyroid-stimulating hormone receptor antibody), the intestine (IgA antitissue transglutaminase antibody), the adrenal gland (anti-21 hydroxylase antibody), and the stomach (antigastric parietal cell antibody and anti-intrinsic factor antibody). Results: Fifty-four patients were included, with an average age of 26 years. GAD, tyrosine phosphatase, and islet cell antibodies were detected in 74%, 22%, and 3.7%, respectively, of the 54 patients examined. The prevalence of extrapancreatic autoimmunity was 45% with a large preponderance among different immunities of those from thyroid and celiac diseases (CDs). Conclusion: Our results confirm that patients with Type 1 diabetes should be investigated for the presence of autoimmune diseases mainly from thyroid and CDs.
20
Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
Roland Tisch, Xiaodong Yang, Steven M. Singer et al. · Nature · 1993 · 950 citations
Medicine, Endocrinology, Immunology +12
Thyroid Disorders and Diabetes Mellitus
Mira S. Zantout, Sami T. Azar · Journal of Thyroid Research · 2011 · 329 citations · Full text
Medicine, Endocrinology, Diabetology +11
Thyroid Autoimmunity in Children and Adolescents With Type 1 Diabetes
Olga Kordonouri, A Klinghammer, Egbert B. Lang et al. · Diabetes Care · 2002 · 310 citations · Full text
Medicine, Endocrinology, Pediatrics +15
Additional Autoimmune Disease Found in 33% of Patients at Type 1 Diabetes Onset
Taylor M. Triolo, Taylor Armstrong, Kim McFann et al. · Diabetes Care · 2011 · 195 citations · Full text
Medicine, Endocrinology, Pediatrics +17